News
EQS-News: Media and Games Invest held its Extraordinary General Meeting - Shareholders a.o. resolve to relocate the company's registered office from Malta to Sweden and to appoint Deloitte Sweden as new auditor
EQS-News: Media and Games Invest held its Extraordinary General Meeting - Shareholders a.o. resolve to relocate the company's registered office from Malta to Sweden and to appoint Deloitte Sweden as new auditor
EQS-News: UET United Electronic Technology AG with revenues growth amid challenging market conditions in first half of fiscal year 2022
EQS-News: UET United Electronic Technology AG with revenues growth amid challenging market conditions in first half of fiscal year 2022
Portfolio Company Imara Announces Merger Agreement with Enliven Therapeutics
Portfolio Company Imara Announces Merger Agreement with Enliven Therapeutics
EQS-News: UET United Electronic Technology AG plans expansion of the current financing round for investments
EQS-News: UET United Electronic Technology AG plans expansion of the current financing round for investments
Arix Portfolio Company Aura Biosciences Presents Interim Phase 2 Data Highlighting Belzupacap Sarotalocan (AU-011) Suprachoroidal Efficacy and Safety at AAO 2022
Arix Portfolio Company Aura Biosciences Presents Interim Phase 2 Data Highlighting Belzupacap Sarotalocan (AU-011) Suprachoroidal Efficacy and Safety at AAO 2022
DGAP-News: Notice and Agenda of the Extraordinary General Meeting
DGAP-News: Notice and Agenda of the Extraordinary General Meeting
DGAP-News: Media and Games Invest SE held its Annual General Meeting
DGAP-News: Media and Games Invest SE held its Annual General Meeting
DGAP-News: Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall
DGAP-News: Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall
DGAP-News: Media and Games Invest: Strong Q2’22 with 37% Overall and 18% Organic Revenue Growth. Confirmation of Guidance 2022. Focusing on Organic Growth, Increasing Profitability as well as Deleveraging
DGAP-News: Media and Games Invest: Strong Q2’22 with 37% Overall and 18% Organic Revenue Growth. Confirmation of Guidance 2022. Focusing on Organic Growth, Increasing Profitability as well as Deleveraging
DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Heliad has signed the UN-supported Principles for Responsible Investments (PRI)
DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Heliad has signed the UN-supported Principles for Responsible Investments (PRI)
DGAP-News: Media and Games Invest Promote Ad-Tech Veterans Ionut Ciobotaru and Sameer Sondhi to C-Level Managers
DGAP-News: Media and Games Invest Promote Ad-Tech Veterans Ionut Ciobotaru and Sameer Sondhi to C-Level Managers
Media and Games Invest Promote Ad-Tech Veterans Ionut Ciobotaru and Sameer Sondhi to C-Level Managers
Media and Games Invest Promote Ad-Tech Veterans Ionut Ciobotaru and Sameer Sondhi to C-Level Managers
DGAP-News: Dermapharm Holding SE: Successful first half of 2022 in challenging market environment
DGAP-News: Dermapharm Holding SE: Successful first half of 2022 in challenging market environment
DGAP-News: Media and Games Invest SE: The Nomination Committee Proposes the Appointment of Deloitte Sweden as the New Auditor Following its Relocation to Sweden
DGAP-News: Media and Games Invest SE: The Nomination Committee Proposes the Appointment of Deloitte Sweden as the New Auditor Following its Relocation to Sweden
DGAP-News: Media and Games Invest: Items 12 and 16 Will Be Withdrawn from the AGM 2022 Agenda and Will Be Clarified and Re‑Proposed for Shareholder Approval at the EGM Covering the Appointment of the New Auditor
DGAP-News: Media and Games Invest: Items 12 and 16 Will Be Withdrawn from the AGM 2022 Agenda and Will Be Clarified and Re‑Proposed for Shareholder Approval at the EGM Covering the Appointment of the New Auditor
Artios initiates Phase 2 study of Polθ Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast Cancer
Artios initiates Phase 2 study of Polθ Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast Cancer
Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini Therapeutics
Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini Therapeutics
Arix Bioscience plc Announces Changes to Board of Directors
Arix Bioscience plc Announces Changes to Board of Directors
Interim Results for the Six Months Ended 30 June 2022
Interim Results for the Six Months Ended 30 June 2022
DGAP-News: Media and Games Invest SE will publish its Half Year Report 2022 on August 31, 2022, and presents the Q2’22 results at its Capital Markets Day in Stockholm on the same day
DGAP-News: Media and Games Invest SE will publish its Half Year Report 2022 on August 31, 2022, and presents the Q2’22 results at its Capital Markets Day in Stockholm on the same day